Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
301 - Does clinical trial advertising material need to be pre-cleared? If so, by who?
-
Messages/announcements aligned with the "Clinical Trial Recruitment" section of the Health Canada policy document "The Distinction Between Advertising and Other Activities" are not subject to the advertising provisions in the PAAB code. Having said that, PAAB offers an advisory opinion based on the aforementioned Health Canada document. This opinion provides the assurance of an objective external review that the message/announcement is indeed aligned with that Health Canada document. Note that, in some cases, a Telecaster number may be required for broadcasting media (e.g. television and/or radio) and receipt of that number may be contingent on demonstration of a "no further comments" letter from PAAB or Ad Standards Canada. Note that HCP advertisements require PAAB review whether they contain Clinical Trial Recruitments or not. Please refer to all industry ethics standards Code of Ethical Practices for guidance on activities related to retaining the services of a stakeholder and communication with stakeholders involved in post registration clinical studies.
